Body Weight

Azstarys improved sleep habits and did not affect growth rates in children with ADHD, according to two recent studies.

SAN DIEGO — Adults with obesity and without diabetes receiving the oral GLP-1 receptor agonist orforglipron lost 8.6% to 12.6% of their body weight at 26 weeks, according to a data from a phase 2 trial.

CHICAGO — Women with polycystic ovary syndrome may have more concerns about their body image compared with those without PCOS, according to findings from a systematic review and meta-analysis presented at ENDO 2023.

The United States Department of Agriculture’s MyPlate intervention could be a practical weight management alternative for patients who struggle with counting calories, according to researchers.

Compared with daily calorie restriction, time-restricted eating did not achieve additional benefits for reducing intrahepatic triglyceride content or body fat among patients with nonalcoholic fatty liver disease and obesity.

Among children and adolescents with acne, prescription systemic medications were more likely to be used by those with a higher BMI than those with a low or normal BMI, according to a study.

Findings from a meta-regression analysis indicated that the beneficial effects of SGLT2 inhibition on CV death and HF hospitalization in patients with diabetes may be related to body weight.

A first-in-class duodenal mucosal resurfacing therapy is associated with reductions in HbA1c and body weight at 24 weeks among a cohort of insulin-treated adults with type 2 diabetes, according to a company press release.

Adults with type 2 diabetes who lost at least 10% of their body weight engaged in more physical activity and slept better at 12 and 24 months than those who lost less weight, according to a study published in Diabetic Medicine.

Infants with a late diagnosis for cystic fibrosis were more likely to be behind in their weight and height at 1 year and height at 3 and 5 years, according to a poster presented at the North American Cystic Fibrosis Conference.